Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CCEL
CCEL logo

CCEL Valuation

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Historical Valuation

Cryo-Cell International Inc (CCEL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 131.83. The fair price of Cryo-Cell International Inc (CCEL) is between +Inf to +Inf according to relative valuation method. Compared to the current price of 3.62 USD , Cryo-Cell International Inc By Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price:3.62
Fair
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Unlock 5-Year Valuation Change
Is Cryo-Cell International Inc (CCEL) at a historical peak or a rare bargain? Access the full 5-year trend to find out.
Unlock Now
Cryo-Cell International Inc (CCEL) has a current Price-to-Book (P/B) ratio of -1.62. Compared to its 3-year average P/B ratio of -226.03, the current P/B ratio is approximately -99.28% higher. Relative to its 5-year average P/B ratio of -137.85, the current P/B ratio is about -98.82% higher. Cryo-Cell International Inc (CCEL) has a Forward Free Cash Flow (FCF) yield of approximately 16.53%. Compared to its 3-year average FCF yield of 6.59%, the current FCF yield is approximately 150.73% lower. Relative to its 5-year average FCF yield of 5.04%, the current FCF yield is about 228.19% lower.

Competitors Valuation Multiple

AI Analysis
The average P/S ratio for CCEL competitors is 0.04, providing a benchmark for relative valuation. Cryo-Cell International Inc Corp (CCEL.A) exhibits a P/S ratio of --, which is -100% above the industry average. Given its robust revenue growth of -2.26%, this premium appears unsustainable.
P/E
P/S
EV/EBITDA
EV/EBIT
Earnings Growth
Market Cap

Performance Decomposition

AI Analysis
1Y
3Y
5Y
Market capitalization of CCEL increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00% to the performance.
Overall, the performance of CCEL in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CCEL currently overvalued or undervalued?

Cryo-Cell International Inc (CCEL) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 131.83. The fair price of Cryo-Cell International Inc (CCEL) is between +Inf to +Inf according to relative valuation method. Compared to the current price of 3.62 USD, Cryo-Cell International Inc is Undervalued By Fair.

What is Cryo-Cell International Inc (CCEL) fair value?

CCEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Cryo-Cell International Inc (CCEL) is between +Inf to +Inf according to relative valuation method.

How does CCEL's valuation metrics compare to the industry average?

The average P/S ratio for CCEL's competitors is 0.04, providing a benchmark for relative valuation. Cryo-Cell International Inc Corp (CCEL) exhibits a P/S ratio of --, which is -100.00% above the industry average. Given its robust revenue growth of -2.26%, this premium appears unsustainable.

What is the current P/B ratio for Cryo-Cell International Inc (CCEL) as of Apr 17 2026?

As of Apr 17 2026, Cryo-Cell International Inc (CCEL) has a P/B ratio of -1.62. This indicates that the market values CCEL at -1.62 times its book value.

What is the current FCF Yield for Cryo-Cell International Inc (CCEL) as of Apr 17 2026?

As of Apr 17 2026, Cryo-Cell International Inc (CCEL) has a FCF Yield of 16.53%. This means that for every dollar of Cryo-Cell International Inc's market capitalization, the company generates 16.53 cents in free cash flow.

What is the current Forward P/E ratio for Cryo-Cell International Inc (CCEL) as of Apr 17 2026?

As of Apr 17 2026, Cryo-Cell International Inc (CCEL) has a Forward P/E ratio of 2000.00. This means the market is willing to pay $2000.00 for every dollar of Cryo-Cell International Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Cryo-Cell International Inc (CCEL) as of Apr 17 2026?

As of Apr 17 2026, Cryo-Cell International Inc (CCEL) has a Forward P/S ratio of 0.00. This means the market is valuing CCEL at $0.00 for every dollar of expected revenue over the next 12 months.